Suffwan Eltom

Suffwan Eltom is an experienced professional in the biopharmaceutical industry, currently serving as Chief of Staff in the BioPharmaceuticals Business Unit at AstraZeneca since April 2022, with prior roles including Senior Director & Group Lead for CVRM - Global Insights & Business Excellence and Director for CVRM - Global Insights, Analytics & Commercial Excellence. Previously, Suffwan Eltom held various positions at Deallus from January 2015 to March 2022, progressing from Senior Manager to Consultant. Additional experience includes a tenure as a Senior Associate at Imperial Consultants (ICON) and a Post-Doctoral Research Associate at Imperial College London, where the focus was on inflammasome-mediated inflammation related to chronic obstructive pulmonary disease (COPD). Suffwan Eltom's educational background encompasses a PhD in Respiratory Pharmacology from Imperial College London and a BSc in Pharmacology & Genomics from King's College London.